858-449-1310 contact@somatek.com

Et cetera

RNA therapeutics

To those developing treatments for oncology, in the gene therapy space and many other fields it seemed for a long time that RNA-based therapies have many attractive properties but somehow just too many obstacles to overcome. Enter recent break-throughs in vaccine...

read more

Molecule(s) of the year

Inspired by Time's Man of the Year the AAAS journal Science used to give out an annual Molecule of the Year award. The award was renamed Breakthrough of the Year in 1996. Last December AAAS announced that for 2020 Breakthrough of the Year was “vaccines against...

read more

Clinical trials in the time of COVID-19

FDA has issued guidelines  for the conduct of clinical trials during the COVID-19 pandemic. “With this guidance issued today, the FDA is helping industry and investigators navigate the COVID-19 pandemic and help assess how to move forward with critical clinical...

read more

New website aggregates global COVID-19 information

Data scientists at Scripps Research in La Jolla, California launched a new website to boost SARS-CoV-2 / COVID-19 research data usability for all. The site Outbreak.info focuses on aggregating SARS-CoV-2 / COVID-19 metadata in a single site with the goal of making...

read more

Happy Earth Day

Team Somatek celebrated Earth Day with a hearty lunch of plant-based burgers from Beyond Meat. Very tasty indeed. Look for it in your local market https://www.beyondmeat.com    

read more

Happy Summer!

Somatek wishes all associates, clients and friends a happy Independence Day, joyous Bastille Day, delicious National Ice Cream Day (July 15th : ) and, if you are watching, an exciting FIFA World Cup.

read more

Mark Fitchmun visits Infors HT

Somatek is increasing its upstream capabilities to serve the needs of existing and future clients. The objective is to support research scale and manufacturing scale upstream processes and integrate those with Somatek’s establish core strengths in downstream and assay...

read more